Selection of AmpC β-lactamase variants and metallo-β-lactamases leading to ceftolozane/tazobactam and ceftazidime/avibactam resistance during treatment of MDR/XDR Pseudomonas … A Ruedas-López, I Alonso-García, C Lasarte-Monterrubio, ... Antimicrobial Agents and Chemotherapy 66 (2), e02067-21, 2022 | 30 | 2022 |
Assessment of activity and resistance mechanisms to cefepime in combination with the novel β-lactamase inhibitors zidebactam, taniborbactam, and enmetazobactam against a … JC Vázquez-Ucha, C Lasarte-Monterrubio, P Guijarro-Sánchez, M Oviaño, ... Antimicrobial Agents and Chemotherapy 66 (2), e01676-21, 2022 | 30 | 2022 |
Activity of cefiderocol, imipenem/relebactam, cefepime/taniborbactam and cefepime/zidebactam against ceftolozane/tazobactam-and ceftazidime/avibactam-resistant Pseudomonas … C Lasarte-Monterrubio, PA Fraile-Ribot, JC Vázquez-Ucha, G Cabot, ... Journal of Antimicrobial Chemotherapy 77 (10), 2809-2815, 2022 | 22 | 2022 |
Emergence of 16S rRNA methyltransferases among carbapenemase-producing Enterobacterales in Spain studied by whole-genome sequencing J Arca-Suárez, BK Rodiño-Janeiro, A Pérez, P Guijarro-Sánchez, ... International Journal of Antimicrobial Agents 59 (1), 106456, 2022 | 16 | 2022 |
Activity of aztreonam in combination with novel β-lactamase inhibitors against metallo-β-lactamase-producing Enterobacterales from Spain JC Vázquez-Ucha, I Alonso-Garcia, P Guijarro-Sánchez, ... International Journal of Antimicrobial Agents 61 (4), 106738, 2023 | 8 | 2023 |
Occurrence of the p019 Gene in the blaKPC-Harboring Plasmids: Adverse Clinical Impact for Direct Tracking of KPC-Producing Klebsiella pneumoniae by Matrix … E Gato, IP Constanso, BK Rodiño-Janeiro, P Guijarro-Sánchez, T Alioto, ... Journal of Clinical Microbiology 59 (8), 10.1128/jcm. 00238-21, 2021 | 8 | 2021 |
Simultaneous and divergent evolution of resistance to cephalosporin/β-lactamase inhibitor combinations and imipenem/relebactam following ceftazidime/avibactam treatment of MDR … I Alonso-García, JC Vázquez-Ucha, C Lasarte-Monterrubio, ... Journal of Antimicrobial Chemotherapy 78 (5), 1195-1200, 2023 | 5 | 2023 |
Carbapenem Resistance in Acinetobacter nosocomialis and Acinetobacter junii Conferred by Acquisition of blaOXA-24/40 and Genetic Characterization of the … C Lasarte-Monterrubio, P Guijarro-Sánchez, A Bellés, JC Vázquez-Ucha, ... Microbiology Spectrum 10 (1), e02734-21, 2022 | 5 | 2022 |
In vitro development of imipenem/relebactam resistance in KPC-producing Klebsiella pneumoniae involves multiple mutations including OmpK36 disruption and KPC modification E Gato, P Guijarro-Sánchez, I Alonso-García, R Pedraza-Merino, A Conde, ... International Journal of Antimicrobial Agents 62 (4), 106935, 2023 | 4 | 2023 |
Antimicrobial activity of cefiderocol against the carbapenemase-producing enterobacter cloacae complex and characterization of reduced susceptibility associated with metallo-β … C Lasarte-Monterrubio, P Guijarro-Sánchez, JC Vázquez-Ucha, ... Antimicrobial agents and chemotherapy 67 (5), e01505-22, 2023 | 4 | 2023 |
Activity of Imipenem, Meropenem, Cefepime, and Sulbactam in Combination with the β-Lactamase Inhibitor LN-1-255 against Acinetobacter spp. C Lasarte-Monterrubio, JC Vazquez-Ucha, M Maneiro, J Arca-Suarez, ... Antibiotics 10 (2), 210, 2021 | 4 | 2021 |
Interplay between OXA-10 β-Lactamase Production and Low Outer-Membrane Permeability in Carbapenem Resistance in Enterobacterales I Alonso-García, JC Vázquez-Ucha, M Martínez-Guitián, ... Antibiotics 12 (6), 999, 2023 | 2 | 2023 |
Epidemiology, resistance genomics and susceptibility of Acinetobacter species: results from the 2020 Spanish nationwide surveillance study C Lasarte-Monterrubio, P Guijarro-Sánchez, I Alonso-Garcia, M Outeda, ... Eurosurveillance 29 (15), 2300352, 2024 | 1 | 2024 |
Reply to Shapiro, “Cefepime/Enmetazobactam Is a Clinically Effective Combination Targeting Extended-Spectrum β-Lactamase-Producing Enterobacterales” JC Vázquez-Ucha, C Lasarte-Monterrubio, P Guijarro-Sánchez, M Oviaño, ... Antimicrobial Agents and Chemotherapy 66 (5), e00353-22, 2022 | 1 | 2022 |
Activity of cefiderocol and innovative β-lactam/β-lactamase inhibitor combinations against isogenic strains of Escherichia coli expressing single and double β-lactamases under … T Blanco-Martín, I Alonso-García, L González-Pinto, M Outeda-García, ... International Journal of Antimicrobial Agents 63 (5), 107150, 2024 | | 2024 |
Activity of aztreonam in combination with novel, B-lactamase inhibitors against metallo-, B-lactamase-producing Enterobacterales from Spain JC Vazquez-Ucha, I Alonso-Garcia, P Guijarro-Sanchez, ... INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS 61 (4), 2023 | | 2023 |
Selection of AmpC b-Lactamase Variants and Metallo-b-Lactamases Leading to Ceftolozane/Tazobactam and Ceftazidime/Avibactam Resistance during Treatment of MDR/XDR Pseudomonas … A Ruedas-López, I Alonso-García, C Lasarte-Monterrubio, ... | | |